(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
A photographer finds thousands of dinosaur footprints near Italian Winter Olympic venue - 2The most effective method to Begin Your Excursion in Gold Venture
- 3Figure out How to Acquire Rewarding Open Record Rewards
- 4Track down Your Optimal Conservative Vehicle: Famous Brands to Consider
- 5Top 10 Moving Style Architects of the Year
- Flying without a Real ID? That'll soon cost you $45, TSA says.
- Disability rights activist and author Alice Wong dies at 51
- Joshua Made Last-Second Seat Change That Saved His Life
- The last penny was pressed by the U.S. Mint in Philadelphia today. Could the nickel and dime be next?
- Brilliant and Gleaming: Excellence and Skincare Practices
- 'We were genuinely astonished': This moss survived 9 months outside the International Space Station and could still grow on Earth
- Reveal Less popular Authentic Realities You Didn't Learn in School
- 'All Her Fault' ending explained: The shocking conclusion to the psychological thriller inspired by true events
- Investigating the Medical advantages of Aloe Vera
